anti-FGFR3 antibody-drug conjugate LY3076226
Term · Oncology and biomedicine · MLC-T-ONC-010656
An antibody-drug conjugate (ADC) composed of a human monoclonal antibody against the fibroblast growth factor receptor type 3 (FGFR3) that is conjugated to an undisclosed cytotoxic agent, with potential antineoplastic activity. Upon administration, the antibody moiety of anti-FGFR3 ADC LY3076226 binds to FGFR3. Upon internalization, the cytotoxic moiety causes cell death in FGFR3-expressing tumor cells. FGFR3, a receptor tyrosine kinase upregulated or mutated in many tumor cell types, plays a key role in tumor cell proliferation.
| Identifier | MLC-T-ONC-010656 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-FGFR3 ADC LY3076226; ADC LY3076226; anti-fibroblast growth factor receptor 3 antibody-drug conjugate LY3076226 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010656",
"term": "anti-FGFR3 antibody-drug conjugate LY3076226",
"field": "Oncology and biomedicine",
"definition": "An antibody-drug conjugate (ADC) composed of a human monoclonal antibody against the fibroblast growth factor receptor type 3 (FGFR3) that is conjugated to an undisclosed cytotoxic agent, with potential antineoplastic activity. Upon administration, the antibody moiety of anti-FGFR3 ADC LY3076226 binds to FGFR3. Upon internalization, the cytotoxic moiety causes cell death in FGFR3-expressing tumor cells. FGFR3, a receptor tyrosine kinase upregulated or mutated in many tumor cell types, plays a key role in tumor cell proliferation.",
"synonyms": [
"anti-FGFR3 ADC LY3076226",
"ADC LY3076226",
"anti-fibroblast growth factor receptor 3 antibody-drug conjugate LY3076226"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-fgfr3-antibody-drug-conjugate-ly3076226/"
}
Record 1,756 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.